Dyne Therapeutics Inc (DYN) stock saw a modest uptick, ending the day at $14.55 which represents a slight increase of $0.42 or 2.97% from the prior close of $14.13. The stock opened at $14.3 and ...
Royal Bank of Canada restated their outperform rating on shares of Lexeo Therapeutics (NASDAQ:LXEO – Free Report) in a report published on Tuesday morning,Benzinga reports. Royal Bank of Canada ...
Zura Bio Limited (NASDAQ:ZURA – Get Free Report) has been given an average rating of “Buy” by the seven ratings firms that ...
In a challenging market environment, DFLI, the stock for Chardan Nextech Acquisition 2, has reached a 52-week low, dipping to $2.49. According to InvestingPro analysis, the company's financial health ...
Richard Giroux, the Chief Financial Officer and Chief Operating Officer of MeiraGTx Holdings plc (NASDAQ:MGTX), a biotechnology company with a market capitalization of $500 million, recently executed ...